Surveillance of cytomegalovirus infection in haematopoietic stem cell transplantation patients

Conclusions. Our result suggests that AGM and N-PCR can be used as markers for assessing the monitoring and the introduction pre-emptive therapy. This approach could prove to be more cost-effective than ganciclovir universal prophylaxis for treating CMV infection.